Health Service Medical Supplies (Costs) Bill

I am grateful to my hon. Friend for raising that issue. Although the measures he mentions are not...

Further to that question, I can see how the Bill will deal with the issue of debranding, and that...

It will deal with some of those concerns, and we will listen to all the concerns raised by hon. M...

I welcome the provisions of the Bill that will close a loophole and deal with terrible examples o...

My hon. Friend is right in that we see demand for NHS services, which includes treatment and drug...

What assessment has my right hon. Friend made of the impact this Bill might have on the parallel ...

My hon. Friend obviously knows about these matters in a great deal of detail and should be reassu...

The early part of the Bill appears incredibly tortuous, because it relates to whether something i...

The hon. Gentleman makes an important point. It will be for this House and the Government to refl...

The Secretary of State tells us that £1.24 billion has come back through the rebate, but many are...

Absolutely. The money comes back to the Department of Health and is invested in the NHS. Indeed, ...

Notwithstanding the Bill’s objectives, which I can see are admirable, does the Secretary of State...

Yes. My hon. Friend makes an important point. The third part of the Bill will provide for much be...

Further to that important point about biosimilars, and in welcoming this legislation and the oppo...

I am happy to look into that—some of my own constituents have been affected by that issue. I am n...

I voted for the 2006 Act, but I have to say to the Secretary of State that profit controls are pr...

Our march on to the centre ground carries on apace. [Laughter.] In response to the hon. Gentleman...

I hope that not only the Opposition but Government Members are reassured by those comments in res...

I am happy to give that reassurance. As I said, this industry contributes £56 billion to the UK e...

We agree that this is not about profit controls—about having a fair return for investment made—bu...

My hon. Friend is right about that. The nice way of putting it is that we are closing a loophole....

I very much agree with the point that the Secretary of State has just made. He talked about colla...

I cannot give the right hon. Gentleman that indication because, as he will know, the CMA operates...

Has my right hon. Friend made any assessment of how the prices of the drugs quoted in the article...

We have made some assessments of those things, but, in essence, our concern is that, even without...

In this regard, will my right hon. Friend be giving consideration to asking pharmacies that can p...

The information we collect might make it possible for us more robustly to analyse issues such as ...

I thank the Secretary of State for outlining the overarching principles of this Bill, which, as w...

May I declare an interest as a type 2 diabetic and chair of the all-party diabetes group? Ten per...

I thank my right hon. Friend for his intervention and pay tribute to him for his great work on di...

My hon. Friend will know—I am sure that we all know this—that there is a difference between the l...

My hon. Friend is absolutely right. That is one reason why we must tread carefully, and hear what...

Does my hon. Friend agree that pharmacists often know their patients much better than over-stretc...

My hon. Friend is absolutely right. There was real concern about the announcement last week. From...

The hon. Gentleman has been fair in his broad analysis of the problems that we face between the s...

I agree that it is important that we keep the dialogue open with industry. We are proud of what t...

My hon. Friend speaks of the abuse of a dominant market position, and this Bill extends the power...

My hon. Friend tempts me a little way outside my brief. I note, though, that our health service i...

Where the advertising budgets of pharmaceutical companies dwarf their R&D budgets, is there not a...

We will not get very far with this Government on corporation tax. They have been going in a direc...

Does my hon. Friend agree that we have to be careful not to discourage drug companies from doing ...

My hon. Friend is absolutely right. We must be careful of the law of unintended consequences with...

As any constituency MP will know, the pressures on the NHS grow year in, year out, partly because...

According to the Library briefing, since the Bill’s publication the share price of Concordia Inte...

I am grateful to the hon. Gentleman for sharing that information.

Equally important, the Bi...

Like the right hon. Member for Chelmsford (Sir Simon Burns), I pay tribute to some of the researc...

The hon. Lady is making a powerful speech, as ever. May I pick her medical brains, as it were, on...

That is an area that needs to be looked at. A narrow definition that covers only blades and swabs...

The hon. Lady is making an informed and impassioned speech. Does she agree that we are entering a...

Absolutely. We have entered the realms of using immunotherapies such as Herceptin for cancer. Equ...

It is a pleasure to follow the extremely well informed speech given by the hon. Member for Centra...

The hon. Gentleman is extolling the work that The Times did in a series of articles this June. Ma...

If memory serves, it was a team of investigative journalists from The Sunday Times that focused o...

This is an uncontroversial set of measures and I confirm my support for the Bill as it stands. Th...

Does the right hon. Gentleman recognise that we are one of a tiny handful of OECD countries that ...

I note that point. I suppose my overall point is that given the unsustainable increase in the tot...

It is a pleasure to speak in support of the Bill, which affects my constituents in north Wales as...

It is a pleasure to follow my hon. Friend the Member for Vale of Clwyd (Dr Davies) and to hear ma...

I am grateful to my new friend, another socialist, for giving way. May I tempt him to suggest som...

The hon. Gentleman tempts me, but I see you are now in the Chair, Mr Deputy Speaker, and you are ...

And you shall not be tempted.

That is good to know.

We have seen work the Government have done in other sectors, for exam...

May I suggest another industry it might be worth looking at, where this situation obtains, namely...

I thank the hon. Gentleman for that intervention. As a member of the Public Accounts Committee I ...

It is a pleasure to be called to speak and to follow my hon. Friend the Member for Torbay (Kevin ...

Coupling those two points together, does the hon. Lady agree that it might be advisable for the G...

The hon. Gentleman makes a very good point. There is already a cut-off for some of the data colle...

It is a pleasure to follow my hon. Friend the Member for Erewash (Maggie Throup).

We all kn...

I wonder whether the hon. Lady remembers the time we spent in the House last November debating th...

I thank the hon. Lady for making the point so succinctly. I am also grateful to the Secretary of ...

I thank all Members who have made contributions to the debate. We find ourselves in a situation w...

I would like to cite for my hon. Friend and the House the Library briefing, which shows that it i...

No, but I think the hon. Member for Torbay was talking about companies that are not doing any res...

I want to be clear about this point. I think the shadow Minister would probably agree that certai...

Very much so.

The hon. Member for Bury St Edmunds (Jo Churchill) welcomed the Bill and talk...

What a great pleasure it is, Mr Deputy Speaker, to stand before you after this important debate, ...

Perhaps I was not clear enough, but I was not making that point. I was making the point that the ...

Just to reassure the hon. Lady, I can tell her that the establishment cost for each pharmacy is c...

First, may I say in passing that it does not sound very draconian if the powers have never been e...

I think the hon. Gentleman may be making a pitch to the Committee of Selection and I would be del...